In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brexit: The UK MHRA's View Of The Elephant In The Room

Executive Summary

UK preparations for a Brexit deal with the EU are not following the smooth path that the UK government would like, as more and more complications emerge. The executive bodies charged with translating Brexit seamlessly into UK policy and law can only watch and wait, but the MHRA, for one, has a strong feel for what is best for UK health care stakeholders.

You may also be interested in...

2017: Year Of The New EU Medtech Regulations: But Is EU Ready?

2017 is going to be a pivotal year for EU medtech regulations. We are expecting the new Medical Devices Regulation and IVD Regulation to take effect. But there are some big concerns and uncertainties at the center of it all.

Is The UK Still Open For Medtech Innovation And Reimbursement?

Confusing and ineffective channels of innovation adoption and a lack of funding hamper the UK's reputation as one of the world's health care capitals and a driver of care excellence – in spite of its global brands, NICE, MHRA and the NHS itself. But changes that should transform market access are in place and are worthy of close attention in the next two to three years.

European Court Opinion Raises Questions About Notified Body Liability

An opinion from an advocate general at the EU Court of Justice could have an impact on whether TÜV Rheinland is found liable and might have to pay damages in the PIP breast implant case, raising broader issues about liability insurance for notified bodies.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts